SP
ABBV icon

Stablepoint Partners’s AbbVie ABBV Stock Holding History

Stablepoint Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.45M Sell
21,670
-216
-1% -$46.5K 0.75% 51
2026
Q1 		$4.76M Sell
21,886
-638
-3% -$142K 0.71% 51
2025
Q4 		$5.15M Buy
22,524
+177
+0.8% +$40.3K 0.8% 44
2025
Q3 		$5.17M Buy
22,347
+110
+0.5% +$22.4K 0.82% 44
2025
Q2 		$4.13M Buy
22,237
+131
+0.6% +$24.3K 0.7% 52
2025
Q1 		$4.63M Buy
22,106
+396
+2% +$77K 0.84% 44
2024
Q4 		$3.86M Buy
21,710
+81
+0.4% +$14.9K 0.71% 51
2024
Q3 		$4.27M Buy
21,629
+171
+0.8% +$31.9K 0.78% 49
2024
Q2 		$3.9M Sell
21,458
-351
-2% -$58.1K 0.76% 52
2024
Q1 		$3.97M Buy
21,809
+4,420
+25% +$762K 0.81% 47
2023
Q4 		$2.69M Buy
+17,389
New +$2.54M 0.69% 52

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Stablepoint Partners's ABBV Position: Q2 2026 in Review

Stablepoint Partners reduced its AbbVie (ABBV) stake by 0.99% in Q2 2026, selling an estimated $46.5K and leaving 21,670 shares worth $5.45M. The position accounts for 0.75% of the portfolio, ranked #51.

Stablepoint Partners first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Stablepoint Partners held 21,670 shares of AbbVie worth $5.45M as of Q2 2026.
  • Stablepoint Partners sold 216 AbbVie shares in Q2 2026, an estimated $46.5K.
  • AbbVie made up 0.75% of Stablepoint Partners's portfolio in Q2 2026, its #51 holding.
  • Stablepoint Partners first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.